340B Legislation Introduced
On Thursday, December 21st, Rep. Larry Bucshon (R-IN) and Rep. Scott Peters (D-CA) introduced the 340B PAUSE Act, H.R. 4710, in the U.S. House of Representatives. The bill would “amend…
Update on 340B Ceiling Price and Manufacturer Civil Monetary Penalties
The White House Office of Management and Budget (OMB) has posted an abstract of HRSA’s new proposed rule on 340B Ceiling Price and Manufacturer Civil Monetary Penalties (CMP). The abstract…
Ryan White Clinics in 340B Program Call for Constructive Dialogue
Washington, D.C. — “For over two decades, the 340B drug pricing program has been a cornerstone of Ryan White providers’ efforts to fight the HIV/AIDS epidemic in the United States,”…
NIH Director Says March-In Rights Cannot Be Used to Lower Drug Prices
National Institutes of Health (NIH) Director Francis Collins stated yesterday that the agency does not have the authority to use its “march-in” rights as a tool to lower drug prices. …